Gratus Capital LLC
- SEC CIK
- 0001652103
- Latest filing
- Jul 25, 2024
ALLO holding history
Allogene Therapeutics, Inc. in every 13F filed by Gratus Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALLO overviewAll 13F holders of ALLOFull Q2 2024 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −238,159−100.0% | Sold out | Holders |
| Q3 2022 | 238,159 | $2.57M | 0.3% | +24,173+11.3% | Added | Holders |
| Q2 2022 | 213,986 | $2.44M | 0.3% | +11,546+5.7% | Added | Holders |
| Q1 2022 | 202,440 | $1.84M | 0.2% | +10,569+5.5% | Added | Holders |
| Q4 2021 | 191,871 | $2.86M | 0.3% | +191,871 | New | Holders |